Depiction of Prostate Cancer Treatment Alternatives in Greece

AstraZeneca

Status: Completed

Conditions: Locally Advanced or Metastatic Prostate Cancer.

Study type: Observational

Funder types: Industry

Identifiers

NCT00733213

NIS-OGR-DUM-2007/1

Details and patient eligibility

About

A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.

• Target Group: Patients with locally advanced or metastatic prostate cancer.
• The first 10 consecutive patients records that meet the entry criteria.

Enrollment: 310 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with Locally advanced or Metastatic Prostate Cancer after 2002.
• Patients that received Hormonal therapy.

Exclusion criteria

• Males that are aged less than 18 years